https://www.prnewswire.com/news-releases/lipocine-announces-positive-lpcn-1144-nash-open-label-extension-study-results-301545697.html
LPCN 1144 was well tolerated over 72-week exposure with no observed safety signals
Liver injury markers were reduced and maintained with extended LPCN 1144...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.